title: Cost-effectiveness of transcatheter versus surgical management of structural heart disease.
abstract: Transcatheter management of valvular and structural heart disease is the most growing aspect of interventional cardiology. While the early experience was limited to patients who were not candidate for surgery, the continuous improvement in the efficacy and safety expanded its use to different degree depending on the procedure and the disease involved. The cost of these procedures is a major concern for health care in developed world. Cost-effectiveness of these transcatheter structural procedures varies depending on the procedure itself, the burden of the underlying disease, the feasibility and cost of both the Transcatheter and surgical procedures. In this review, we turn now to a specific discussion of the medical economics of percutaneous valvular and structural interventions.
authors.affiliation: Division of Cardiology, University of Kansas School of Medicine, Kansas City, KS. Electronic address: zfanari@gmail.com.
authors.forename: Zaher
authors.initials: Z
authors.lastname: Fanari
authors.affiliation: Section of Cardiology, Christiana Care Health System, Newark, DE; Value institute, Christiana Care Health System, Newark, DE.
authors.forename: William S
authors.initials: WS
authors.lastname: Weintraub
mesh_terms: D006328:Cardiac Catheterization / Q000191:economics*; D003362:Cost-Benefit Analysis / Q000706:statistics & numerical data*; D006331:Heart Diseases / Q000191:economics* / Q000601:surgery / Q000628:therapy*; D019918:Heart Valve Prosthesis Implantation / Q000191:economics*; D006801:Humans
keywords: Cost-effectiveness; Surgery; Transcatheter aortic valve replacement; Transcatheter structural intervention